Medical Devices & Tech

Minrad International

50 Cobham Drive
Orchard Park, NY 14127 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Inhalation anesthetics and real-time image guidance technologies for use in surgical procedures

Management William H. Burns Jr., Chairman of the Board, Chief Executive Officer; David T. DiGiacinto, President, Chief Operating Officer, Director; Charles R. Trego Jr., Chief Financial Officer, Executive Vice President; Dennis Goupil Ph.D, Executive Vice President, Chief Technology Officer; John McNeirney, Senior Vice President; Kirk Kamsler, Senior Vice President, Commercial Development; Terence D. Vollrath, Vice President, Operations; Karen L. Sonnhalter MBA, Vice President, Principal Accounting Officer, Controller; William Rolfe, Vice President, Treasurer; David Donaldson, Director

Click here for Financial Data
Keywords: pharmaceuticals, anesthetics, halogenated, enflurane, fluoroscopic


Updated: Aug. 22, 2013


Piramal Healthcare Limited will acquire Minrad International for $.12 per share plus the assumption of debt. The total transaction, valued at approximately $40 million, is expected to close in the fir......view more

Products / Services

Anesthesia & Analgesia: Compound 347 (enflurane USP), Terrell (isoflurane USP), and Sojourn (sevoflurane): and MR tested Laryngoscope handles and blades. Real Time Image Guidance: SabreSource imagi......view more

Technology / Differentiation

MINRAD's inhalation anesthetics are generic. The company's imaging technology differ from alternative approaches in that they are: performed in real-time; have an accuracy claim of +/-1 mm at 1 meter;...view more

Market / Customers

MINRAD focuses on acute care specialists in anesthesia, pain management, neurosurgery, orthopedics and interventional radiology. 80% of present revenue is from international markets through its exclus......view more

Competitors / Substitutes / Alternatives

Inhalant Anesthetics: Abbott Laboratories and Baxter International Image Guidance: Sofomor-Danek (Medtronic, Inc.) and Brain-Lab Conscious Sedation: Nitrous Oxide and intravenous benzodiazepine...view more


The company is committed to the development and commercialization of "Products of Hope" & acute care devices or pharmaceuticals that will dramatically improve outcomes for patients and medical staff....view more


The company has 13 issued U.S. patents and nine U.S. patent pending with corresponding applications internationally. Seventeen medical devices have received FDA 510(k) clearance. Minrad has two ANDA'...view more